Evidence map›Paper›PMID 16230468›Full record

ArticleThe Journal of general physiology2005

Defining the retinoid binding site in the rod cyclic nucleotide-gated channel.

Diana M Horrigan, Michelle L Tetreault, Natia Tsomaia, Chrysoula Vasileiou, Babak Borhan, Dale F Mierke, Rosalie K Crouch, Anita L Zimmerman

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of general physiology, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Diana M HorriganDepartment of Molecular Pharmacology, Physiology, and Biotechnology, Brown Medical School, Providence, RI 02912, USA.
Michelle L Tetreault
Natia Tsomaia
Chrysoula Vasileiou
Babak Borhan
Dale F Mierke
Rosalie K Crouch
Anita L Zimmerman
Brown University · USMichigan State University · USMedical University of South Carolina · US

Funding

STUDIES OF RPE65R01EY012231 · NEI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI MA, JIAN-XING, MOISEYEV, GENNADIY · 1998 to 2021
$5.7M
SYNTHETIC RETINAL PIGMENTS AND BINDING PROTEINSR01EY004939 · NEI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI CROUCH, ROSALIE K · 1985 to 2011
$4.2M
G PROTEIN RECEPTOR - STRUCTURAL CHARACTERIZATIONR01GM054082 · NIGMS · DARTMOUTH COLLEGE · PI MIERKE, DALE F · 2002 to 2010
$2.6M
PROPERTIES OF LIGHT-MODULATED ION CHANNELS IN THE RETINAR01EY007774 · NEI · BROWN UNIVERSITY · PI ZIMMERMAN, ANITA L · 1988 to 2005
$1.8M
Bioorganic Studies of Retinal Binding ProteinsR01GM067311 · NIGMS · MICHIGAN STATE UNIVERSITY · PI BORHAN, BABAK · 2003 to 2007
$1.1M
G PROTEIN/RECEPTOR ASSOC--STRUCTURAL CHARACTERIZATIONR29GM054082 · NIGMS · CLARK UNIVERSITY (WORCESTER, MA) · PI MIERKE, DALE F · 1996 to 2000
$112k
NEI NIH HHS EY04939NEI NIH HHS EY07774NEI NIH HHS EY12231NEI NIH HHS R01 EY004939NEI NIH HHS R01 EY007774NEI NIH HHS R01 EY012231NIGMS NIH HHS GM067311NIGMS NIH HHS GM54082NIGMS NIH HHS R01 GM054082NIGMS NIH HHS R01 GM067311NIGMS NIH HHS R29 GM054082
6 · The paper itself

Abstract

Rod vision is initiated when 11-cis-retinal, bound within rhodopsin, absorbs a photon and isomerizes to all-trans-retinal (ATR). This triggers an enzyme cascade that lowers cGMP, thereby closing cyclic nucleotide-gated (CNG) channels. ATR then dissociates from rhodopsin, with bright light releasing millimolar levels of ATR. We have recently shown that ATR is a potent closed-state inhibitor of the rod CNG channel, and that it requires access to the cytosolic face of the channel (McCabe, S.L., D.M. Pelosi, M. Tetreault, A. Miri, W. Nguitragool, P. Kovithvathanaphong, R. Mahajan, and A.L. Zimmerman. 2004. J. Gen. Physiol. 123:521-531). However, the details of the interaction between the channel and ATR have not been resolved. Here, we explore the nature of this interaction by taking advantage of specific retinoids and retinoid analogues, namely, beta-ionone, all-trans-C15 aldehyde, all-trans-C17 aldehyde, all-trans-C22 aldehyde, all-trans-retinol, all-trans-retinoic acid, and all-trans-retinylidene-n-butylamine. These retinoids differ in polyene chain length, chemical functionality, and charge. Results obtained from patch clamp and NMR studies have allowed us to better define the characteristics of the site of retinoid-channel interaction. We propose that the cytoplasmic face of the channel contains a retinoid binding site. This binding site likely contains a hydrophobic region that allows the ionone ring and polyene tail to sit in an optimal position to promote interaction of the terminal functional group with residues approximately 15 A away from the ionone ring. Based on our functional data with retinoids possessing either a positive or a negative charge, we speculate that these amino acid residues may be polar and/or aromatic.

Indexed as

AnimalsBinding SitesCyclic Nucleotide-Gated Cation ChannelsDose-Response Relationship, DrugElectrophysiologyIon ChannelsNorisoprenoidsOocytesPatch-Clamp TechniquesRetinaldehydeRetinal Rod Photoreceptor CellsRetinoidsXenopus laevisCyclic Nucleotide-Gated Cation ChannelsIon ChannelsNorisoprenoidsRetinaldehydeRetinoids

Identifiers

PMID16230468
PMCPMC2266610
OpenAlexW2136798835

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.